WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive Income (Loss), Net of Tax
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive Income (Loss), Net of Tax of -$23.40 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-21.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2023-02-21
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-03-31 was -$42.70M, a 5437.50% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), net of tax for the quarter ending 2019-12-31 was $20.80M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), net of tax for the quarter ending 2019-09-30 was -$18.20M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), net of tax for the quarter ending 2019-06-30 was $1.20M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$23.40M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), net of tax for fiscal 2021 was -$49.00M, a 225.64% decline from fiscal 2020.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), net of tax for fiscal 2020 was $39.00M, a 747.83% increase from fiscal 2019.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), net of tax for fiscal 2019 was $4.60M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$23.40M 10-K · filed 2023-02-21 | |||
| 2021-12-31 | -$49.00M 10-K · filed 2023-02-21 | |||
| 2020-12-31 | $39.00M 10-K · filed 2023-02-21 | |||
| 2020-03-31 | -$42.70M 10-Q · filed 2020-04-24 | -$21.90M derived: sum of 2 quarters · filed 2022-02-22 | -$40.10M derived: sum of 3 quarters · filed 2022-02-22 | -$38.90M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $20.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $2.60M derived: sum of 2 quarters · filed 2022-02-22 | $3.80M derived: sum of 3 quarters · filed 2022-02-22 | $4.60M 10-K · filed 2022-02-22 |
| 2019-09-30 | -$18.20M 10-Q · filed 2019-10-29 | -$17.00M derived: sum of 2 quarters · filed 2019-10-29 | -$16.20M 10-Q · filed 2019-10-29 | -$16.60M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $1.20M 10-Q · filed 2019-10-29 | $2.00M 10-Q · filed 2019-07-29 | $1.60M derived: sum of 3 quarters · filed 2021-02-23 | -$8.50M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $800.00K 10-Q · filed 2020-04-24 | $400.00K derived: sum of 2 quarters · filed 2021-02-23 | -$9.70M derived: sum of 3 quarters · filed 2021-02-23 | -$57.60M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$10.50M derived: sum of 2 quarters · filed 2021-02-23 | -$58.40M derived: sum of 3 quarters · filed 2021-02-23 | -$36.90M 10-K · filed 2021-02-23 |
| 2018-09-30 | -$10.10M 10-Q · filed 2019-10-29 | -$58.00M derived: sum of 2 quarters · filed 2019-10-29 | -$36.50M 10-Q · filed 2019-10-29 | -$23.20M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | -$47.90M 10-Q · filed 2019-10-29 | -$26.40M 10-Q · filed 2019-07-29 | -$13.10M derived: sum of 3 quarters · filed 2020-02-24 | $8.10M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $21.50M 10-Q · filed 2019-10-29 | $34.80M derived: sum of 2 quarters · filed 2020-02-24 | $56.00M derived: sum of 3 quarters · filed 2020-02-24 | $83.20M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $13.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $34.50M derived: sum of 2 quarters · filed 2020-02-24 | $61.70M derived: sum of 3 quarters · filed 2020-02-24 | $69.50M 10-K · filed 2020-02-24 |
| 2017-09-30 | $21.20M 10-Q · filed 2018-10-30 | $48.40M derived: sum of 2 quarters · filed 2018-10-30 | $56.20M 10-Q · filed 2018-10-30 | $13.20M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $27.20M 10-Q · filed 2018-07-31 | $35.00M 10-Q · filed 2018-07-31 | -$8.00M derived: sum of 3 quarters · filed 2019-02-28 | -$1.50M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $7.80M 10-Q · filed 2018-05-08 | -$35.20M derived: sum of 2 quarters · filed 2019-02-28 | -$28.70M derived: sum of 3 quarters · filed 2019-02-28 | -$31.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$36.50M derived: sum of 2 quarters · filed 2019-02-28 | -$38.80M derived: sum of 3 quarters · filed 2019-02-28 | -$24.20M 10-K · filed 2019-02-28 |
| 2016-09-30 | $6.50M 10-Q · filed 2017-10-31 | $4.20M derived: sum of 2 quarters · filed 2017-10-31 | $18.80M 10-Q · filed 2017-10-31 | $10.60M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | -$2.30M 10-Q · filed 2017-08-01 | $12.30M 10-Q · filed 2017-08-01 | $4.10M derived: sum of 3 quarters · filed 2018-02-26 | $9.90M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $14.60M 10-Q · filed 2017-05-05 | $6.40M derived: sum of 2 quarters · filed 2018-02-26 | $12.20M derived: sum of 3 quarters · filed 2018-02-26 | $22.30M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | -$8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$2.40M derived: sum of 2 quarters · filed 2018-02-26 | $7.70M derived: sum of 3 quarters · filed 2018-02-26 | -$43.40M 10-K · filed 2018-02-26 |
| 2015-09-30 | $5.80M 10-Q · filed 2016-10-31 | $15.90M derived: sum of 2 quarters · filed 2016-10-31 | -$35.20M 10-Q · filed 2016-10-31 | -$83.10M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $10.10M 10-Q · filed 2016-08-01 | -$41.00M 10-Q · filed 2016-08-01 | -$88.90M derived: sum of 3 quarters · filed 2017-02-28 | -$125.50M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | -$51.10M 10-Q · filed 2016-05-06 | -$99.00M derived: sum of 2 quarters · filed 2017-02-28 | -$135.60M derived: sum of 3 quarters · filed 2017-02-28 | -$136.50M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$47.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$84.50M derived: sum of 2 quarters · filed 2017-02-28 | -$85.40M derived: sum of 3 quarters · filed 2017-02-28 | -$86.80M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$36.60M 10-Q · filed 2015-11-02 | -$37.50M derived: sum of 2 quarters · filed 2015-11-02 | -$38.90M 10-Q · filed 2015-11-02 | -$1.80M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | -$900.00K 10-Q · filed 2015-08-03 | -$2.30M 10-Q · filed 2015-08-03 | $34.80M derived: sum of 3 quarters · filed 2016-02-26 | $56.70M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$1.40M 10-Q · filed 2015-05-06 | $35.70M derived: sum of 2 quarters · filed 2016-02-26 | $57.60M derived: sum of 3 quarters · filed 2016-02-26 | $58.60M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $37.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $59.00M derived: sum of 2 quarters · filed 2016-02-26 | $60.00M derived: sum of 3 quarters · filed 2016-02-26 | $43.50M 10-K · filed 2016-02-26 |
| 2013-09-30 | $21.90M 10-Q · filed 2014-11-03 | $22.90M derived: sum of 2 quarters · filed 2014-11-03 | $6.40M 10-Q · filed 2014-11-03 | $2.20M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $1.00M 10-Q · filed 2014-08-01 | -$15.50M 10-Q · filed 2014-08-01 | -$19.70M derived: sum of 3 quarters · filed 2015-02-25 | -$2.70M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | -$16.60M 10-Q · filed 2014-05-08 | -$20.70M derived: sum of 2 quarters · filed 2015-02-25 | -$3.70M derived: sum of 3 quarters · filed 2015-02-25 | -$34.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $12.90M derived: sum of 2 quarters · filed 2015-02-25 | -$17.40M derived: sum of 3 quarters · filed 2015-02-25 | -$4.40M 10-K · filed 2015-02-25 |
| 2012-09-30 | $17.00M 10-Q · filed 2013-11-04 | -$13.30M derived: sum of 2 quarters · filed 2013-11-04 | -$300.00K 10-Q · filed 2013-11-04 | -$47.30M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | -$30.30M 10-Q · filed 2013-08-05 | -$17.30M 10-Q · filed 2013-08-05 | -$64.30M derived: sum of 3 quarters · filed 2014-02-27 | -$88.20M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $13.00M 10-Q · filed 2013-05-06 | -$34.00M derived: sum of 2 quarters · filed 2014-02-27 | -$57.90M derived: sum of 3 quarters · filed 2014-02-27 | -$47.60M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | -$47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$70.90M derived: sum of 2 quarters · filed 2014-02-27 | -$60.60M derived: sum of 3 quarters · filed 2014-02-27 | -$40.20M 10-K · filed 2014-02-27 |
| 2011-09-30 | -$23.90M 10-Q · filed 2012-11-05 | -$13.60M derived: sum of 2 quarters · filed 2012-11-05 | $6.80M 10-Q · filed 2012-11-05 | |
| 2011-06-30 | $10.30M 10-Q · filed 2012-08-06 | $30.70M 10-Q · filed 2012-08-06 | ||
| 2010-12-31 | -$11.60M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |